These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18829992)

  • 21. Letter by Barlis et al regarding article, "Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Barlis P; Dimopoulos K; Di Mario C
    Circulation; 2008 Oct; 118(18):e679; author reply e681. PubMed ID: 18955673
    [No Abstract]   [Full Text] [Related]  

  • 22. Bifurcation lesions: the last great frontier for coronary interventions.
    Botas J
    Rev Esp Cardiol; 2008 Sep; 61(9):911-3. PubMed ID: 18775230
    [No Abstract]   [Full Text] [Related]  

  • 23. Data collection efforts made easy.
    Hosp Case Manag; 1995 Oct; 3(10):161-2. PubMed ID: 10153565
    [No Abstract]   [Full Text] [Related]  

  • 24. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.
    Goeree R; Bowen JM; Blackhouse G; Lazzam C; Cohen E; Chiu M; Hopkins R; Tarride JE; Tu JV
    Int J Technol Assess Health Care; 2009 Apr; 25(2):196-207. PubMed ID: 19331710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
    Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative assessment of rheumatoid hand surgery in various regions of the world.
    Kotsis SV; Chung KC
    J Hand Surg Am; 2005 Jul; 30(4):649-57. PubMed ID: 16039353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
    Kirtane AJ; Gupta A; Iyengar S; Moses JW; Leon MB; Applegate R; Brodie B; Hannan E; Harjai K; Jensen LO; Park SJ; Perry R; Racz M; Saia F; Tu JV; Waksman R; Lansky AJ; Mehran R; Stone GW
    Circulation; 2009 Jun; 119(25):3198-206. PubMed ID: 19528338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart health - CHD management gaps in general practice.
    Huang N; Daddo M; Clune E
    Aust Fam Physician; 2009 Apr; 38(4):241-5. PubMed ID: 19350075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection.
    Ren X; Trilesskaya M; Kwan DM; Nguyen K; Shaw RE; Hui PY
    Am J Cardiol; 2009 Jul; 104(2):216-22. PubMed ID: 19576350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
    Carlsson J; James SK; Lindbäck J; Scherstén F; Nilsson T; Stenestrand U; Lagerqvist B;
    J Am Coll Cardiol; 2009 Apr; 53(16):1389-98. PubMed ID: 19371822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage.
    Jaffe J; AlKhawam L; Du H; Tobin K; O'Leary J; Pollock G; Batjer HH; Awad IA
    Neurosurgery; 2009 Mar; 64(3):436-45; discussion 445-6. PubMed ID: 19240605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpreting outcomes.
    Zink T; Yawn B
    Minn Med; 1998 Jan; 81(1):16-7. PubMed ID: 9465579
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro MS; Dibra A; Musto C; De Santis A; Violini R
    J Invasive Cardiol; 2008 Dec; 20(12):651-4. PubMed ID: 19057029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery].
    Sheiban I; Zoccai GB; Moretti C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):113-7; discussion 117. PubMed ID: 19348149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.